Single User
£3750
PDF
70 pages

Ankylosing Spondylitis Forecast in 13 Major Markets 2017-2027


Ankylosing Spondylitis (AkS) is a chronic, systemic inflammatory autoimmune disease. It primarily affects the sacro-iliac joints of the hip and pelvis, but extends to the axial skeleton. Patients experience low back pain and increased stiffness.

This report provides the current prevalent population for Ankylosing Spondylitis across 13 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Turkey, Brazil, Japan, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ankylosing Spondylitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

There are several features associated with Ankylosing Spondylitis, these include:

  • Psoriasis
  • Uveitis
  • IBD
  • Enthesitis
  • peripheral arthritis
  • Pulmonary fibrosis
  • CVD (aortic root / rheumatic heart / AV block and other conduction disorders)
  • Prostatitis (males)
  • Spinal ankylosis and fracture

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
  • Able to quantify patient populations in global Ankylosing Spondylitis market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Ankylosing Spondylitis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Ankylosing Spondylitis prevalent
  • Identify sub-populations within Ankylosing Spondylitis which require
  • Gain an understanding of the specific markets that have the largest number of Ankylosing Spondylitis patients.
Table of Contents
  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Ankylosing Spondylitis
  • Features of Ankylosing Spondylitis Patients
  • Major Symptoms of Ankylosing Spondylitis
  • Comorbid conditions of Ankylosing Spondylitis patients
  • Vertebral fractures in patients with Ankylosing Spondylitis
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix
List of Figures
  • Spinal changes associated with Ankylosing Spondylitis
List of Tables
  • New York Criteria for diagnosis of Ankylosing Spondylitis
  • New York Criteria for grading sacroiliitis
  • Prevalence of Ankylosing Spondylitis, total (000s)
  • Prevalence of Ankylosing Spondylitis, males (000s)
  • Prevalence of Ankylosing Spondylitis, females (000s)
  • Spinal Radiographic Changes in AkS patients, total (000s)
  • Patients by likely origin of AkS, total (000s)
  • Cervical Rotation, total (000s)
  • Sacroliitis Grade (NY criteria), total (000s)
  • AkS patients by Smoking status, total (000s)
  • Ankylosing Spondylitis patients with HLA-B27 mutation, total (000s)
  • Ankylosing Spondylitis patients with Sarcoiliac pain, total (000s)
  • Ankylosing Spondylitis patients with Low back pain, total (000s)
  • Ankylosing Spondylitis patients with Enthesitis, total (000s)
  • Ankylosing Spondylitis patients with Dactylitis, total (000s)
  • Ankylosing Spondylitis patients with Peripheral Arthritis, total (000s)
  • Ankylosing Spondylitis patients with Anxiety, total (000s)
  • Ankylosing Spondylitis patients with Depression, total (000s)
  • Ankylosing Spondylitis patients with Urolithiasis, total (000s)
  • Ankylosing Spondylitis patients with Inflammatory Bowel Disease, total (000s)
  • Ankylosing Spondylitis patients with Psoriasis, total (000s)
  • Ankylosing Spondylitis patients with Uveitis, total (000s)
  • Ankylosing Spondylitis patients with Asthma, total (000s)
  • Ankylosing Spondylitis patients with Hay-fever, total (000s)
  • Ankylosing Spondylitis patients with Eczema, total (000s)
  • Ankylosing Spondylitis patients with Obstructive Sleep Apnoea, total (000s)
  • Ankylosing Spondylitis patients with Elevated CRP, total (000s)
  • Ankylosing Spondylitis patients with BASDAI ≥ 4, total (000s)
  • Ankylosing Spondylitis patients with Hip Involvement, total (000s)
  • Ankylosing Spondylitis patients with Bamboo Spine, total (000s)
  • Ankylosing Spondylitis patients with Pulmonary Abnormality on HRCT, total (000s)
  • Ankylosing Spondylitis patients with Cervical Spine Involvement, total (000s)
  • Ankylosing Spondylitis patients with First-Degree AV Block, total (000s)
  • Ankylosing Spondylitis patients with Prolonged QRS interval, total (000s)
  • Ankylosing Spondylitis patients with Shoulder Disorders, total (000s)
  • Ankylosing Spondylitis patients with Vertebral Fractures, total (000s)
  • Location of Vertebral Fractures in AkS patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • USA Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Canada Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Canada Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • France Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • France Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Germany Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Germany Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Italy Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Italy Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Spain Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Spain Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • UK Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • UK Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Turkey Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Turkey Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Japan Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Japan Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • India Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • India Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • China Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • China Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
  • Russia Prevalence of Ankylosing Spondylitis by 5-yr age cohort, males (000s)
  • Russia Prevalence of Ankylosing Spondylitis by 5-yr age cohort, females (000s)
Brazil, Canada, China, France, Germany, India, Italy, Japan, Russian Federation, Spain, Turkey, United Kingdom, United States of America